SCHEMBL5214263

SCHEMBL5214263

CCOC(=O)c1c(C(=O)N2CCS(O)(O)CC2)c2ccccc2n1Cc1ccc(Cl)c(Cl)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 7/20 0.52
LMNA P02545 3/20 0.48
MAPT P10636 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
GAA P10253 2/20 0.48
HTT P42858 1/20 0.48
ALDH1A1 P00352 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
HPGD P15428 1/20 0.41
CYP2C19 P33261 1/20 0.41
AVPR1A P37288 1/20 0.41
KDM4E B2RXH2 2/20 0.41
F10 P00742 1/20 0.41
POLB P06746 1/20 0.40
CNR2 P34972 1/20 0.40
ABCB11 O95342 1/20 0.40
PTGES O14684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5214254 0.93 CCR2 (0.52) CCR2LMNAMAPTSMN1; SMN2GAA
SCHEMBL5213680 0.85 CCR2 (0.65) CCR2LMNAMAPTSMN1; SMN2GAA
SCHEMBL5214833 0.83 CCR2 (0.48) CCR2LMNAMAPTSMN1; SMN2GAA
SCHEMBL7465366 0.83 CCR2 (0.49) CCR2LMNAMAPTSMN1; SMN2GAA
SCHEMBL6302584 0.83 CCR2 (0.62) CCR2LMNAMAPTSMN1; SMN2GAA
SCHEMBL5214863 0.83 CCR2 (0.76) CCR2LMNAMAPTSMN1; SMN2GAA
SCHEMBL6905363 0.82 CCR2 (0.48) CCR2LMNAMAPTSMN1; SMN2GAA
SCHEMBL5217008 0.80 CCR2 (0.48) CCR2LMNAMAPTSMN1; SMN2GAA
SCHEMBL5220576 0.80 CCR2 (0.61) CCR2LMNAMAPTSMN1; SMN2GAA
SCHEMBL5214927 0.78 CCR2 (0.59) CCR2LMNAMAPTSMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1173421-B1 INDOLE DERIVATIVES AS ANTI-INFLAMMATION AGENTS ASTRAZENECA AB (SE) 2007-10-03 EP disclosed
US-6833387-B1 3-substituted indoles; inhibition of monocyte chemoattractant protein-1 and/or RANTES induced chemotaxis; inflammatory diseases ASTRAZENECA AB (SE) 2004-12-21 US disclosed